Table 2 Kaplan-Meier estimates of overall and cancer-specific survival.

pRCC subtype

<0.001

<0.001

  pRCC 1

140.7

5.78

164

156.1

3.4

164

  pRCC2

93.1

15.55

164

120.2

12.6

164

  Mixed

85.3

13.95

164

98.2

14.5

164

MYC staining

0.625

0.395

  Negative

124

8.94

164

142

6.9

164

  Intermediate

115

7.56

164

133

6.7

164

  Strong

104

20.11

164

150

13.2

164

MYC staining

0.41

0.379

  Negative/strong

121

8.56

163

144

6

163

  Intermediate

115

7.16

163

133

6.3

163

MINA53 staining

0.304

0.243

  Negative

126

7.29

170

149

5.3

170

  Positive

117

9.94

107

134

9.1

170

Ki67 index

0.08

<0.001

  <5%

126

6.29

168

152

4.6

168

  ≥5%

104

11.9

168

119

10.3

168

pRCC subtype + MYC

<0.001

<0.001

  pRCC1 MYC negative/strong

135.1

4.07

141

141

0

141

  pRCC1 MYC intermediate

110.6

7.7

141

129

5.1

141

  pRCC2 MYC negative/strong

72.7

19.49

141

108

14.2

141

  pRCC2 MYC intermediate

91

14.71

141

103

14.3

141

pRCC subtype + MINA53

0.003

<0.001

  pRCC1 MINA53 negative

131.1

6.17

148

141.8

3.8

148

  pRCC1 MINA53 positive

123.5

8.49

148

141.1

5.1

148

  pRCC2 MINA53 negative

86.5

15.7

148

118.2

11.1

148

  pRCC2 MINA53 positive

86.2

25.48

148

86.2

25.48

148

pRCC subtype + Ki67 index

<0.001

<0.001

  pRCC1 Ki67 <5%

94.3

4.18

111

105.6

2.6

111

  pRCC1 Ki67 ≥5%

106.4

4.46

111

106.4

4.5

111

  pRCC2 Ki67 <5%

74.2

12.37

111

97.6

8.9

111

  pRCC2 Ki67 ≥5%

55.8

13.46

111

64.4

13.4

111